Atlas FDA

SBL-3 Intraocular Lens

FDA premarket approval P200020/S001 · decided 2022-09-16

Approval details

PMA number
P200020
Supplement
S001
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
SBL-3 Intraocular Lens
Generic name
Lens, multifocal intraocular
Applicant
Lenstec, Inc.
Date received
2022-08-18
Decision date
2022-09-16
Days to decision
29 days
Decision code
APPR
Product code
MFK
Advisory committee
Ophthalmic
Expedited review
No
Location
St. Petersburg, FL
Statement
Approval of the protocol for the post-approval study (PAS).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Lenstec LC Injection system (K161776)Lenstec, Inc.2016-11-29
LENSTEC LC INJECTION SYSTEM (K122848)Lenstec, Inc.2013-10-18
FLUID ISOLATION DEVICE (K091915)Lenstec, Inc.2009-10-27
LENSTEC LC INJECTION SYSTEM (K063802)Lenstec, Inc.2007-05-07
LENSTEC INTRAOCULAR LENS (IOL) INJECTION SYSTEM (K060533)Lenstec, Inc.2006-04-14
LENSTEC INTRAOCULAR LENS (IOL) INJECTION SYSTEM FOR TETRAFLEX INTRAOCULAR LENSES (K050638)Lenstec, Inc.2005-05-31